Atossa Therapeutics (NASDAQ: ATOS) deepens Z-endoxifen bet as 2025 losses widen and rare disease optionality grows
Read More 1 minute read General news updates US Supreme Court shakes up college admissions policies In a pivotal ruling, the US Supreme Court has come out against race-conscious student admissions policies at Harvard… byPallavi MadhirajuJune 29, 2023